Assessment of the efficacy of a new formulation of minoxidil (DC120) on hair growth, in a minizone model in androgenetic alopecia in men.
Assessment of the efficacy of a new formulation of minoxidil (DC120) on hair growth, in a minizone model in androgenetic alopecia in men.
Assessment of the efficacy of a new formulation of minoxidil (DC120) on hair growth, in a minizone model in androgenetic alopecia in men.
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
65
Years old
Gender
Male
Therapeutic area :
Dermatology
Disease :
Breast cancer
Study medication :
Minoxidil
Phase :
Phase II
Start Date :
21 August 2015
End date :
28 April 2016
Study ID :
DC0120 LE 202
EudraCT/CTIS number :
2014-005573-36
Send by email